NCT03740425View on ClinicalTrials.gov

Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) Study

CompletedOBSERVATIONAL
Enrollment

3,235

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

March 1, 2019

Conditions
Transcatheter Aortic Valve Implantation (TAVI)Blood TransfusionAKIPrognosisAortic Valve Stenosis
Interventions
PROCEDURE

Blood Transfusion

Blood Transfusion in patients who underwent transcatheter aortic valve implantation (TAVI)

Trial Locations (1)

Unknown

Santissima Annunziata Hospital, Chieti

All Listed Sponsors
collaborator

IRCCS Policlinico S. Donato

OTHER

collaborator

University Hospital, Catania

OTHER

collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

collaborator

Hospital Clínico Universitario de Valladolid

OTHER

lead

G. d'Annunzio University

OTHER

NCT03740425 - Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) Study | Biotech Hunter | Biotech Hunter